nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminosalicylic Acid—CHUK—epithelium—gallbladder cancer	0.0259	0.172	CbGeAlD
Aminosalicylic Acid—CHUK—liver—gallbladder cancer	0.0147	0.0975	CbGeAlD
Aminosalicylic Acid—ALOX5—pancreas—gallbladder cancer	0.013	0.0863	CbGeAlD
Aminosalicylic Acid—MPO—epithelium—gallbladder cancer	0.0123	0.082	CbGeAlD
Aminosalicylic Acid—CHUK—lymph node—gallbladder cancer	0.0112	0.0747	CbGeAlD
Aminosalicylic Acid—MPO—pancreas—gallbladder cancer	0.011	0.073	CbGeAlD
Aminosalicylic Acid—PTGS2—gall bladder—gallbladder cancer	0.0108	0.0719	CbGeAlD
Aminosalicylic Acid—CHUK—PI-3K cascade—ERBB4—gallbladder cancer	0.00855	0.0101	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI3K/AKT activation—ERBB4—gallbladder cancer	0.00835	0.00983	CbGpPWpGaD
Aminosalicylic Acid—CHUK—GAB1 signalosome—ERBB4—gallbladder cancer	0.00828	0.00975	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—liver—gallbladder cancer	0.00826	0.0549	CbGeAlD
Aminosalicylic Acid—CHUK—Constitutive PI3K/AKT Signaling in Cancer—ERBB3—gallbladder cancer	0.00821	0.00966	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—BCL2—gallbladder cancer	0.00818	0.00962	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—ERBB4—gallbladder cancer	0.00809	0.00953	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI-3K cascade—ERBB3—gallbladder cancer	0.00739	0.0087	CbGpPWpGaD
Aminosalicylic Acid—MPO—C-MYB transcription factor network—NRAS—gallbladder cancer	0.00728	0.00856	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI3K/AKT activation—ERBB3—gallbladder cancer	0.00722	0.0085	CbGpPWpGaD
Aminosalicylic Acid—CHUK—GAB1 signalosome—ERBB3—gallbladder cancer	0.00716	0.00843	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—ERBB3—gallbladder cancer	0.007	0.00824	CbGpPWpGaD
Aminosalicylic Acid—MPO—liver—gallbladder cancer	0.00699	0.0465	CbGeAlD
Aminosalicylic Acid—MPO—Folate Metabolism—TP53—gallbladder cancer	0.00675	0.00794	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—ERBB4—gallbladder cancer	0.00639	0.00753	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—lymph node—gallbladder cancer	0.00633	0.0421	CbGeAlD
Aminosalicylic Acid—CHUK—Hair Follicle Development: Induction (Part 1 of 3)—EGFR—gallbladder cancer	0.00633	0.00745	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Rac1/Pak1/p38/MMP-2 pathway—ERBB2—gallbladder cancer	0.00629	0.0074	CbGpPWpGaD
Aminosalicylic Acid—MPO—C-MYB transcription factor network—KRAS—gallbladder cancer	0.00626	0.00737	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—ERBB4—gallbladder cancer	0.00612	0.0072	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—ERBB4—gallbladder cancer	0.00602	0.00709	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—epithelium—gallbladder cancer	0.00585	0.0389	CbGeAlD
Aminosalicylic Acid—CHUK—TCR signaling in naïve CD8+ T cells—NRAS—gallbladder cancer	0.00577	0.00679	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—ERBB4—gallbladder cancer	0.00575	0.00677	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Leptin signaling pathway—ERBB2—gallbladder cancer	0.00574	0.00676	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—ERBB4—gallbladder cancer	0.00572	0.00673	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—ERBB4—gallbladder cancer	0.00569	0.0067	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—ERBB4—gallbladder cancer	0.00567	0.00667	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—epithelium—gallbladder cancer	0.00559	0.0372	CbGeAlD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—ERBB4—gallbladder cancer	0.00558	0.00657	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—ERBB3—gallbladder cancer	0.00553	0.00651	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Apoptosis—BCL2—gallbladder cancer	0.0054	0.00635	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PDGF Pathway—HRAS—gallbladder cancer	0.00539	0.00635	CbGpPWpGaD
Aminosalicylic Acid—MPO—lymph node—gallbladder cancer	0.00536	0.0356	CbGeAlD
Aminosalicylic Acid—CHUK—DAP12 interactions—ERBB4—gallbladder cancer	0.00533	0.00627	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—ERBB4—gallbladder cancer	0.00533	0.00627	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—ERBB4—gallbladder cancer	0.00533	0.00627	CbGpPWpGaD
Aminosalicylic Acid—MPO—C-MYB transcription factor network—HRAS—gallbladder cancer	0.00532	0.00626	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—ERBB3—gallbladder cancer	0.00529	0.00622	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—ERBB4—gallbladder cancer	0.00528	0.00622	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—ERBB4—gallbladder cancer	0.00524	0.00616	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—ERBB4—gallbladder cancer	0.00521	0.00614	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—ERBB3—gallbladder cancer	0.00521	0.00613	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Constitutive PI3K/AKT Signaling in Cancer—ERBB2—gallbladder cancer	0.00515	0.00606	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—pancreas—gallbladder cancer	0.00498	0.0331	CbGeAlD
Aminosalicylic Acid—CHUK—Downstream signal transduction—ERBB3—gallbladder cancer	0.00497	0.00585	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR signaling in naïve CD8+ T cells—KRAS—gallbladder cancer	0.00496	0.00584	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—ERBB3—gallbladder cancer	0.00495	0.00582	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—ERBB4—gallbladder cancer	0.00493	0.00581	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—ERBB3—gallbladder cancer	0.00492	0.00579	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—ERBB3—gallbladder cancer	0.0049	0.00577	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Interleukin-11 Signaling Pathway—HRAS—gallbladder cancer	0.0049	0.00576	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR signaling in naïve CD4+ T cells—NRAS—gallbladder cancer	0.00484	0.0057	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—ERBB3—gallbladder cancer	0.00483	0.00568	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Rac1/Pak1/p38/MMP-2 pathway—NRAS—gallbladder cancer	0.00478	0.00563	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—ERBB4—gallbladder cancer	0.00472	0.00556	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI-3K cascade—ERBB2—gallbladder cancer	0.00464	0.00546	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—ERBB3—gallbladder cancer	0.00461	0.00542	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—ERBB3—gallbladder cancer	0.00461	0.00542	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—ERBB3—gallbladder cancer	0.00461	0.00542	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—ERBB3—gallbladder cancer	0.00457	0.00538	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—ERBB3—gallbladder cancer	0.00453	0.00533	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI3K/AKT activation—ERBB2—gallbladder cancer	0.00453	0.00533	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—ERBB3—gallbladder cancer	0.00451	0.0053	CbGpPWpGaD
Aminosalicylic Acid—CHUK—GAB1 signalosome—ERBB2—gallbladder cancer	0.00449	0.00529	CbGpPWpGaD
Aminosalicylic Acid—CHUK—AGE/RAGE pathway—EGFR—gallbladder cancer	0.00441	0.00519	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—ERBB2—gallbladder cancer	0.00439	0.00516	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Rac1/Pak1/p38/MMP-2 pathway—EGFR—gallbladder cancer	0.00436	0.00513	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—ERBB3—gallbladder cancer	0.00426	0.00502	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR signaling in naïve CD8+ T cells—HRAS—gallbladder cancer	0.00422	0.00497	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—KEAP1—gallbladder cancer	0.00419	0.00493	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR signaling in naïve CD4+ T cells—KRAS—gallbladder cancer	0.00417	0.0049	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Rac1/Pak1/p38/MMP-2 pathway—KRAS—gallbladder cancer	0.00412	0.00484	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—ERBB3—gallbladder cancer	0.00408	0.0048	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Aryl Hydrocarbon Receptor—NRAS—gallbladder cancer	0.00383	0.0045	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc-epsilon receptor I signaling in mast cells—HRAS—gallbladder cancer	0.00377	0.00444	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TNF alpha Signaling Pathway—NRAS—gallbladder cancer	0.00371	0.00437	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Rac1/Pak1/p38/MMP-2 pathway—TP53—gallbladder cancer	0.00366	0.00431	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—gallbladder cancer	0.00364	0.00429	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—ERBB4—gallbladder cancer	0.00363	0.00427	CbGpPWpGaD
Aminosalicylic Acid—CHUK—p75(NTR)-mediated signaling—TP53—gallbladder cancer	0.00357	0.00421	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Constitutive PI3K/AKT Signaling in Cancer—EGFR—gallbladder cancer	0.00357	0.0042	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR signaling in naïve CD4+ T cells—HRAS—gallbladder cancer	0.00354	0.00417	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BCR signaling pathway—HRAS—gallbladder cancer	0.0035	0.00412	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Rac1/Pak1/p38/MMP-2 pathway—HRAS—gallbladder cancer	0.0035	0.00412	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Aryl Hydrocarbon Receptor—EGFR—gallbladder cancer	0.00349	0.0041	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—ERBB2—gallbladder cancer	0.00347	0.00408	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—BCL2—gallbladder cancer	0.00338	0.00397	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—ERBB2—gallbladder cancer	0.00332	0.0039	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Aryl Hydrocarbon Receptor—KRAS—gallbladder cancer	0.00329	0.00388	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by Interleukins—NRAS—gallbladder cancer	0.00326	0.00384	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—ERBB2—gallbladder cancer	0.00326	0.00384	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI-3K cascade—EGFR—gallbladder cancer	0.00321	0.00378	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—BCL2—gallbladder cancer	0.0032	0.00376	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Leptin signaling pathway—HRAS—gallbladder cancer	0.0032	0.00376	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TNF alpha Signaling Pathway—KRAS—gallbladder cancer	0.00319	0.00376	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—liver—gallbladder cancer	0.00317	0.0211	CbGeAlD
Aminosalicylic Acid—CHUK—Signaling by NGF—ERBB3—gallbladder cancer	0.00314	0.00369	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI3K/AKT activation—EGFR—gallbladder cancer	0.00314	0.00369	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—ERBB2—gallbladder cancer	0.00312	0.00367	CbGpPWpGaD
Aminosalicylic Acid—CHUK—GAB1 signalosome—EGFR—gallbladder cancer	0.00311	0.00366	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—ERBB2—gallbladder cancer	0.0031	0.00365	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—ERBB2—gallbladder cancer	0.00309	0.00363	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—ERBB2—gallbladder cancer	0.00307	0.00361	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Apoptosis—TP53—gallbladder cancer	0.00305	0.00359	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—gallbladder cancer	0.00304	0.00358	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—ERBB2—gallbladder cancer	0.00303	0.00356	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—ERBB2—gallbladder cancer	0.00289	0.0034	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—ERBB2—gallbladder cancer	0.00289	0.0034	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—ERBB2—gallbladder cancer	0.00289	0.0034	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—ERBB2—gallbladder cancer	0.00286	0.00337	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—ERBB2—gallbladder cancer	0.00284	0.00334	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—ERBB2—gallbladder cancer	0.00283	0.00333	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by Interleukins—KRAS—gallbladder cancer	0.00281	0.00331	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Aryl Hydrocarbon Receptor—HRAS—gallbladder cancer	0.0028	0.0033	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—BCL2—gallbladder cancer	0.0028	0.00329	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR Signaling Pathway—HRAS—gallbladder cancer	0.00276	0.00325	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—ERBB2—gallbladder cancer	0.00272	0.0032	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TNF alpha Signaling Pathway—HRAS—gallbladder cancer	0.00271	0.00319	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—ERBB2—gallbladder cancer	0.00267	0.00315	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—NRAS—gallbladder cancer	0.00264	0.0031	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Receptor Signaling Pathway—HRAS—gallbladder cancer	0.0026	0.00306	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—ERBB2—gallbladder cancer	0.00256	0.00301	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—lymph node—gallbladder cancer	0.00254	0.0169	CbGeAlD
Aminosalicylic Acid—CHUK—Immune System—KEAP1—gallbladder cancer	0.00254	0.00299	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—NRAS—gallbladder cancer	0.00252	0.00297	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—NRAS—gallbladder cancer	0.00248	0.00292	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—lymph node—gallbladder cancer	0.00243	0.0162	CbGeAlD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—EGFR—gallbladder cancer	0.0024	0.00283	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by Interleukins—HRAS—gallbladder cancer	0.00239	0.00281	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—NRAS—gallbladder cancer	0.00237	0.00279	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—NRAS—gallbladder cancer	0.00236	0.00278	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—NRAS—gallbladder cancer	0.00236	0.00278	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—NRAS—gallbladder cancer	0.00235	0.00276	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—NRAS—gallbladder cancer	0.00234	0.00275	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—NRAS—gallbladder cancer	0.0023	0.00271	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—EGFR—gallbladder cancer	0.0023	0.00271	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—EGFR—gallbladder cancer	0.00227	0.00268	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—KRAS—gallbladder cancer	0.00227	0.00267	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—EGFR—gallbladder cancer	0.00226	0.00266	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—NRAS—gallbladder cancer	0.0022	0.00259	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—NRAS—gallbladder cancer	0.0022	0.00259	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—NRAS—gallbladder cancer	0.0022	0.00259	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—NRAS—gallbladder cancer	0.00218	0.00256	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—KRAS—gallbladder cancer	0.00217	0.00256	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—EGFR—gallbladder cancer	0.00216	0.00254	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—NRAS—gallbladder cancer	0.00216	0.00254	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—EGFR—gallbladder cancer	0.00215	0.00253	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—NRAS—gallbladder cancer	0.00215	0.00253	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—KRAS—gallbladder cancer	0.00215	0.00253	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—EGFR—gallbladder cancer	0.00214	0.00252	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—KRAS—gallbladder cancer	0.00214	0.00252	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—EGFR—gallbladder cancer	0.00213	0.00251	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—EGFR—gallbladder cancer	0.0021	0.00247	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—ERBB4—gallbladder cancer	0.00207	0.00244	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—KRAS—gallbladder cancer	0.00204	0.0024	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—KRAS—gallbladder cancer	0.00203	0.00239	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—NRAS—gallbladder cancer	0.00203	0.00239	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—KRAS—gallbladder cancer	0.00203	0.00239	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—KRAS—gallbladder cancer	0.00202	0.00238	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—KRAS—gallbladder cancer	0.00201	0.00237	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—EGFR—gallbladder cancer	0.002	0.00236	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—EGFR—gallbladder cancer	0.002	0.00236	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—EGFR—gallbladder cancer	0.002	0.00236	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—ERBB4—gallbladder cancer	0.00199	0.00234	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—EGFR—gallbladder cancer	0.00198	0.00234	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—KRAS—gallbladder cancer	0.00198	0.00233	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—ERBB2—gallbladder cancer	0.00197	0.00232	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—EGFR—gallbladder cancer	0.00197	0.00232	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—EGFR—gallbladder cancer	0.00196	0.00231	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—NRAS—gallbladder cancer	0.00195	0.00229	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—HRAS—gallbladder cancer	0.00193	0.00227	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—TP53—gallbladder cancer	0.00191	0.00225	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—HRAS—gallbladder cancer	0.0019	0.00223	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—KRAS—gallbladder cancer	0.00189	0.00223	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—KRAS—gallbladder cancer	0.00189	0.00223	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—KRAS—gallbladder cancer	0.00189	0.00223	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—EGFR—gallbladder cancer	0.00188	0.00222	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—KRAS—gallbladder cancer	0.00188	0.00221	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—KRAS—gallbladder cancer	0.00186	0.00219	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—EGFR—gallbladder cancer	0.00185	0.00218	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—KRAS—gallbladder cancer	0.00185	0.00218	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—HRAS—gallbladder cancer	0.00185	0.00217	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—HRAS—gallbladder cancer	0.00182	0.00214	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—ERBB3—gallbladder cancer	0.00179	0.00211	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—KRAS—gallbladder cancer	0.00178	0.0021	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—EGFR—gallbladder cancer	0.00177	0.00209	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—KRAS—gallbladder cancer	0.00175	0.00206	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—HRAS—gallbladder cancer	0.00173	0.00204	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—HRAS—gallbladder cancer	0.00173	0.00204	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—HRAS—gallbladder cancer	0.00173	0.00203	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—ERBB3—gallbladder cancer	0.00172	0.00202	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—HRAS—gallbladder cancer	0.00172	0.00202	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—HRAS—gallbladder cancer	0.00171	0.00201	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—HRAS—gallbladder cancer	0.00168	0.00198	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—KRAS—gallbladder cancer	0.00168	0.00197	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—gallbladder cancer	0.00166	0.00195	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—EGFR—gallbladder cancer	0.00164	0.00193	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—gallbladder cancer	0.00161	0.0019	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—HRAS—gallbladder cancer	0.00161	0.00189	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—HRAS—gallbladder cancer	0.00161	0.00189	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—HRAS—gallbladder cancer	0.00161	0.00189	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—HRAS—gallbladder cancer	0.00159	0.00188	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	0.00158	0.00186	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—HRAS—gallbladder cancer	0.00158	0.00186	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—HRAS—gallbladder cancer	0.00157	0.00185	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—NRAS—gallbladder cancer	0.00152	0.00179	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—NRAS—gallbladder cancer	0.0015	0.00176	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—HRAS—gallbladder cancer	0.00149	0.00175	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—HRAS—gallbladder cancer	0.00142	0.00168	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TP53—gallbladder cancer	0.00138	0.00162	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—EGFR—gallbladder cancer	0.00136	0.00161	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—KRAS—gallbladder cancer	0.00131	0.00154	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—KRAS—gallbladder cancer	0.00129	0.00152	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—ERBB4—gallbladder cancer	0.00121	0.00142	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—BCL2—gallbladder cancer	0.00116	0.00136	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—ERBB2—gallbladder cancer	0.00112	0.00132	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—gallbladder cancer	0.00112	0.00131	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—HRAS—gallbladder cancer	0.00111	0.00131	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—ERBB4—gallbladder cancer	0.00111	0.00131	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—HRAS—gallbladder cancer	0.0011	0.00129	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—ERBB2—gallbladder cancer	0.00108	0.00127	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—gallbladder cancer	0.00105	0.00124	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—ERBB3—gallbladder cancer	0.00104	0.00123	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—ERBB3—gallbladder cancer	0.000963	0.00113	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	0.000937	0.0011	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—NRAS—gallbladder cancer	0.000854	0.00101	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—NRAS—gallbladder cancer	0.00082	0.000965	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ERBB4—gallbladder cancer	0.00078	0.000918	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—EGFR—gallbladder cancer	0.000778	0.000916	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—EGFR—gallbladder cancer	0.000747	0.000879	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—KRAS—gallbladder cancer	0.000735	0.000865	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—KRAS—gallbladder cancer	0.000706	0.000831	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ERBB3—gallbladder cancer	0.000674	0.000794	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—BCL2—gallbladder cancer	0.000673	0.000792	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—ERBB4—gallbladder cancer	0.00066	0.000776	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—ERBB2—gallbladder cancer	0.000654	0.00077	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—HRAS—gallbladder cancer	0.000625	0.000735	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—ERBB2—gallbladder cancer	0.000604	0.000711	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HRAS—gallbladder cancer	0.0006	0.000706	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—ERBB3—gallbladder cancer	0.00057	0.000671	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—NRAS—gallbladder cancer	0.000497	0.000586	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NRAS—gallbladder cancer	0.000459	0.000541	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—EGFR—gallbladder cancer	0.000453	0.000533	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—KRAS—gallbladder cancer	0.000428	0.000504	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ERBB2—gallbladder cancer	0.000423	0.000498	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—EGFR—gallbladder cancer	0.000418	0.000493	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—KRAS—gallbladder cancer	0.000395	0.000465	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HRAS—gallbladder cancer	0.000364	0.000428	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—ERBB2—gallbladder cancer	0.000358	0.000421	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HRAS—gallbladder cancer	0.000336	0.000395	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NRAS—gallbladder cancer	0.000322	0.000379	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—EGFR—gallbladder cancer	0.000293	0.000345	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—KRAS—gallbladder cancer	0.000277	0.000326	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NRAS—gallbladder cancer	0.000272	0.00032	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—EGFR—gallbladder cancer	0.000248	0.000292	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TP53—gallbladder cancer	0.000246	0.00029	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HRAS—gallbladder cancer	0.000235	0.000277	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—KRAS—gallbladder cancer	0.000234	0.000276	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HRAS—gallbladder cancer	0.000199	0.000234	CbGpPWpGaD
